Significance of small bleeds in brain MRI scan and their relation to patients symptoms

Not Applicable

• Conditions: Health Condition 1: G45- Transient cerebral ischemic attacks and related syndromesHealth Condition 2: G46- Vascular syndromes of brain in cerebrovascular diseases

• Registration Number: CTRI/2024/05/066818
• Lead Sponsor: dandapantula sushrutha

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All adults more than 18 years of age presenting with acute ischemic stroke of less than 24 hours duration

Exclusion Criteria

Patients with neoplasms, intracranial surgery, traumatic brain injury, thrombocytopenia, bleeding diathesis, venous hemorrhagic infarcts and metallic implants insitu which is contraindication for MRI brain

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To Determine the prevalence and topographic patterns of cerebral microbleeds in subtypes of acute ischemic stroke <br/ ><br>To compare the vascular risk factors, white matter lesion load, prior antiplatelet or anticoagulant use in patients with and without cerebral microbleeds <br/ ><br>Evaluate the scores of MoCA in patients of acute ischemic stroke with and without cerebral microbleedsTimepoint: To Determine the prevalence and topographic patterns of cerebral microbleeds in subtypes of acute ischemic stroke at the index admission within 24 hours <br/ ><br>To compare the vascular risk factors, white matter lesion load, prior antiplatelet or anticoagulant use in patients with and without cerebral microbleeds at the index admission within 24 hours <br/ ><br>Evaluate the scores of MoCA in patients of acute ischemic stroke with and without cerebral microbleeds at the index admission within 24 hours

Secondary Outcome Measures

Name	Time	Method
To evaluate the presence of hemorrhagic transformation after thrombolysis in patients with & without cerebral microbleedsTimepoint: To evaluate the presence of hemorrhagic transformation after thrombolysis in patients with & without cerebral microbleeds within 24 hours of thrombolysis